Advanced Medical Solutions (AMS)
Advanced Medical Solutions (AMS) began its journey in Egypt as a trusted partner to leading international agencies in cardiovascular care, supplying advanced medical devices to healthcare providers and institutions. This strong foundation established AMS as a reliable source of innovative medical solutions tailored to the needs of the Egyptian market.
Building on this success, AMS has expanded into manufacturing, specializing in sterilization products. With a vision centered on quality and infection control, we operate state-of-the-art factories in Beni Suef, Egypt, covering more than 6,000 square meters. Here, we produce sterilization materials that meet the highest global standards.
Beyond our own product lines, AMS provides OEM manufacturing services, enabling other companies to benefit from world-class sterilization packaging and medical materials produced in Egypt. This ensures both local and regional markets gain access to safe, high-quality solutions.
Through this strategic evolution—from trading to manufacturing—AMS remains committed to delivering advanced medical solutions, uncompromising quality, and operational excellence. Today, we proudly position ourselves as a leader in supporting healthcare innovation across Egypt and the Middle East.
Our Milestones.
Key milestones that shaped Advanced Medical Solutions from its beginnings in 2012 to the manufacturing era.
AMS Started
AMS started in 2012.
Bolton Medical
In 2015, AMS took 55% of the aortic endovascular market share with Bolton Medical.
Major Governmental Tender
In 2017, AMS took 1.2K from the Sharm tender, the biggest governmental tender, and secured a direct contract of 1.7K, reaching 100% market share in the vascular market.
Entering Manufacturing
2019, AMS started its manufacturing era while obtaining The manufacturing license from the egyptian IDA Cretifacte License and Certificate from Egyptian Drug Authority (EDA) .
Applied for the CE MARK CERTIFICATE
In 2025, AMS applied for the CE and Free Sales Certificate, further strengthening its regulatory readiness and supporting the international marketability of its sterlization medical products issued 2026.
HeadOffice - Cairo
Factory - New Beni Suef City